Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
. 2015 Jul 14;3(4):350-9.
doi: 10.1002/iid3.73. eCollection 2015 Dec.

CMTR1 Is Associated With Increased Asthma Exacerbations in Patients Taking Inhaled Corticosteroids

Free PMC article

CMTR1 Is Associated With Increased Asthma Exacerbations in Patients Taking Inhaled Corticosteroids

Amber Dahlin et al. Immun Inflamm Dis. .
Free PMC article


Inhaled corticosteroids (ICS) are the most effective controller medications for asthma, and variability in ICS response is associated with genetic variation. Despite ICS treatment, some patients with poor asthma control experience severe asthma exacerbations, defined as a hospitalization or emergency room visit. We hypothesized that some individuals may be at increased risk of asthma exacerbations, despite ICS use, due to genetic factors. A GWAS of 237,726 common, independent markers was conducted in 806 Caucasian asthmatic patients from two population-based biobanks: BioVU, at Vanderbilt University Medical Center (VUMC) in Tennessee (369 patients), and Personalized Medicine Research Project (PMRP) at the Marshfield Clinic in Wisconsin (437 patients). Using a case-control study design, the association of each SNP locus with the outcome of asthma exacerbations (defined as asthma-related emergency department visits or hospitalizations concurrent with oral corticosteroid use), was evaluated for each population by logistic regression analysis, adjusting for age, gender and the first four principal components. A meta-analysis of the results was conducted. Validation of expression of selected candidate genes was determined by evaluating an independent microarray expression data set. Our study identified six novel SNPs associated with differential risk of asthma exacerbations (P < 10(-05)). The top GWAS result, rs2395672 in CMTR1, was associated with an increased risk of exacerbations in both populations (OR = 1.07, 95% CI 1.03-1.11; joint P = 2.3 × 10(-06)). Two SNPs (rs2395672 and rs279728) were associated with increased risk of exacerbations, while the remaining four SNPs (rs4271056, rs6467778, rs2691529, and rs9303988) were associated with decreased risk. Three SNPs (rs2395672, rs6467778, and rs2691529) were present in three genes: CMTR1, TRIM24 and MAGI2. The CMTR1 mRNA transcript was significantly differentially expressed in nasal lavage samples from asthmatics during acute exacerbations, suggesting potential involvement of this gene in the development of this phenotype. We show that genetic variability may contribute to asthma exacerbations in patients taking ICS. Furthermore, our studies implicate CMTR1 as a novel candidate gene with potential roles in the pathogenesis of asthma exacerbations.

Keywords: Asthma; EMR; GWAS; exacerbations; inhaled corticosteroids; pharmacogenomics.


Figure 1
Figure 1
GWAS results. Plots of –log10 transformed, two‐sided P values (expected vs. observed) for (A) BioVU and (B) PMRP are shown (λ [SE]: in [A] 1.03 [5.4 × 10−05]; in [B] 1.01 [7.6 × 10−06]). (C) The Manhattan plot shows –log10‐transformed association P values for the meta‐analysis, plotted versus chromosome position (x axis). The results were adjusted for age at reported exacerbation event, gender, and the first four principal components. The blue line indicates the P value threshold for suggestive genome‐wide significance (10−05) whereas the red line indicates the genome‐wide significance threshold (10−07).
Figure 2
Figure 2
Differential Expression of CMTR1. The expression of CMTR1 mRNA transcripts was evaluated using a publicly available dataset (GEO accession GSE30326) from a microarray analysis of nasal lavage samples obtained from asthmatic children during and after asthma exacerbation 35. The y axis represents normalized expression values of CMTR1 from 32 paired mRNA samples.

Similar articles

See all similar articles

Cited by 11 articles

  • Advances in asthma and allergic disease genetics: Is bigger always better?
    Schoettler N, Rodríguez E, Weidinger S, Ober C. Schoettler N, et al. J Allergy Clin Immunol. 2019 Dec;144(6):1495-1506. doi: 10.1016/j.jaci.2019.10.023. Epub 2019 Oct 31. J Allergy Clin Immunol. 2019. PMID: 31677964
  • Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management.
    Bleecker ER, Menzies-Gow AN, Price DB, Bourdin A, Sweet S, Martin AL, Alacqua M, Tran TN. Bleecker ER, et al. Am J Respir Crit Care Med. 2020 Feb 1;201(3):276-293. doi: 10.1164/rccm.201904-0903SO. Am J Respir Crit Care Med. 2020. PMID: 31525297 Free PMC article.
  • A host gene expression approach for identifying triggers of asthma exacerbations.
    Lydon EC, Bullard C, Aydin M, Better OM, Mazur A, Nicholson BP, Ko ER, McClain MT, Ginsburg GS, Woods CW, Burke TW, Henao R, Tsalik EL. Lydon EC, et al. PLoS One. 2019 Apr 8;14(4):e0214871. doi: 10.1371/journal.pone.0214871. eCollection 2019. PLoS One. 2019. PMID: 30958855 Free PMC article.
  • RNA 2'-O-Methylation (Nm) Modification in Human Diseases.
    Dimitrova DG, Teysset L, Carré C. Dimitrova DG, et al. Genes (Basel). 2019 Feb 5;10(2):117. doi: 10.3390/genes10020117. Genes (Basel). 2019. PMID: 30764532 Free PMC article. Review.
  • Genome-wide association study of inhaled corticosteroid response in admixed children with asthma.
    Hernandez-Pacheco N, Farzan N, Francis B, Karimi L, Repnik K, Vijverberg SJ, Soares P, Schieck M, Gorenjak M, Forno E, Eng C, Oh SS, Pérez-Méndez L, Berce V, Tavendale R, Samedy LA, Hunstman S, Hu D, Meade K, Farber HJ, Avila PC, Serebrisky D, Thyne SM, Brigino-Buenaventura E, Rodriguez-Cintron W, Sen S, Kumar R, Lenoir M, Rodriguez-Santana JR, Celedón JC, Mukhopadhyay S, Potočnik U, Pirmohamed M, Verhamme KM, Kabesch M, Palmer CNA, Hawcutt DB, Flores C, Maitland-van der Zee AH, Burchard EG, Pino-Yanes M. Hernandez-Pacheco N, et al. Clin Exp Allergy. 2019 Jun;49(6):789-798. doi: 10.1111/cea.13354. Epub 2019 Feb 15. Clin Exp Allergy. 2019. PMID: 30697902 Free PMC article.
See all "Cited by" articles


    1. (GINA). GIfA. Global strategy for asthma management and prevention: Update 2012. 2012.
    1. (NAEPP). NAEaPP. Expert panel Report 3: Guidelines for the diagnosis and management of asthma [Publication 08‐405]. Bethesda, MD: National Institutes of Health; 2007.
    1. Jarjour N. N., Erzurum S. C., Bleecker E. R., W. J. Calhoun, M. Castro, S. A. Comhair, K. F. Chung, D. Curran‐Everett, R. A. Dweik, S. B. Fain, et al. 2012. Severe asthma: lessons learned from the national heart, lung, and blood institute severe asthma research program. Am. J. Respir. Crit. Care. Med. 185(4):356–362. - PMC - PubMed
    1. Bahadori K., Doyle‐Waters M. M., Marra C., Lynd L., Alasaly K., Swiston J., FitzGerald J. M.. 2009. Economic burden of asthma: a systematic review. BMC Pulm. Med. 9:24. - PMC - PubMed
    1. Chan M. T., Leung D. Y., Szefler S. J., and Spahn J. D.. 1998. Difficult‐to‐control asthma: clinical characteristics of steroid‐insensitive asthma. J. Allergy Clin. Immunol. 101(5):594–601. - PubMed

LinkOut - more resources